nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—SHBG—semen—hepatitis B	0.0364	0.232	CbGeAlD
Medroxyprogesterone Acetate—AR—semen—hepatitis B	0.0261	0.167	CbGeAlD
Medroxyprogesterone Acetate—Abdominal pain lower—Telbivudine—hepatitis B	0.0178	0.029	CcSEcCtD
Medroxyprogesterone Acetate—Body odor—Lamivudine—hepatitis B	0.0146	0.0238	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—blood plasma—hepatitis B	0.0133	0.0847	CbGeAlD
Medroxyprogesterone Acetate—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.0118	0.0193	CcSEcCtD
Medroxyprogesterone Acetate—Skin odour abnormal—Lamivudine—hepatitis B	0.0109	0.0177	CcSEcCtD
Medroxyprogesterone Acetate—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00986	0.0161	CcSEcCtD
Medroxyprogesterone Acetate—Hepatomegaly—Entecavir—hepatitis B	0.00973	0.0159	CcSEcCtD
Medroxyprogesterone Acetate—Glycosuria—Entecavir—hepatitis B	0.0085	0.0139	CcSEcCtD
Medroxyprogesterone Acetate—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.0083	0.0135	CcSEcCtD
Medroxyprogesterone Acetate—Hepatomegaly—Telbivudine—hepatitis B	0.008	0.013	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—blood plasma—hepatitis B	0.00771	0.0491	CbGeAlD
Medroxyprogesterone Acetate—Hoarseness—Lamivudine—hepatitis B	0.00725	0.0118	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—blood plasma—hepatitis B	0.0069	0.044	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—blood plasma—hepatitis B	0.00684	0.0436	CbGeAlD
Medroxyprogesterone Acetate—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.00672	0.011	CcSEcCtD
Medroxyprogesterone Acetate—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0066	0.0108	CcSEcCtD
Medroxyprogesterone Acetate—Tenderness—Telbivudine—hepatitis B	0.00649	0.0106	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—blood—hepatitis B	0.00647	0.0413	CbGeAlD
Medroxyprogesterone Acetate—Musculoskeletal pain—Telbivudine—hepatitis B	0.00573	0.00934	CcSEcCtD
Medroxyprogesterone Acetate—Pregnancy—Lamivudine—hepatitis B	0.00562	0.00917	CcSEcCtD
Medroxyprogesterone Acetate—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00558	0.00911	CcSEcCtD
Medroxyprogesterone Acetate—Hepatic failure—Entecavir—hepatitis B	0.00556	0.00908	CcSEcCtD
Medroxyprogesterone Acetate—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00543	0.00885	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—blood plasma—hepatitis B	0.00522	0.0333	CbGeAlD
Medroxyprogesterone Acetate—Anaphylactoid reaction—Entecavir—hepatitis B	0.00517	0.00843	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—liver—hepatitis B	0.00506	0.0323	CbGeAlD
Medroxyprogesterone Acetate—Sepsis—Telbivudine—hepatitis B	0.00491	0.00801	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—blood—hepatitis B	0.00486	0.031	CbGeAlD
Medroxyprogesterone Acetate—Blood creatinine increased—Entecavir—hepatitis B	0.00468	0.00764	CcSEcCtD
Medroxyprogesterone Acetate—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00457	0.00745	CcSEcCtD
Medroxyprogesterone Acetate—Hepatomegaly—Lamivudine—hepatitis B	0.00451	0.00735	CcSEcCtD
Medroxyprogesterone Acetate—PGR—blood—hepatitis B	0.00438	0.0279	CbGeAlD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0043	0.00702	CcSEcCtD
Medroxyprogesterone Acetate—Pain in extremity—Telbivudine—hepatitis B	0.00411	0.0067	CcSEcCtD
Medroxyprogesterone Acetate—Migraine—Telbivudine—hepatitis B	0.00404	0.00659	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Entecavir—hepatitis B	0.00402	0.00655	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Entecavir—hepatitis B	0.0039	0.00636	CcSEcCtD
Medroxyprogesterone Acetate—Dysphonia—Lamivudine—hepatitis B	0.00388	0.00632	CcSEcCtD
Medroxyprogesterone Acetate—Blood disorder—Lamivudine—hepatitis B	0.00382	0.00623	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00381	0.00622	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—liver—hepatitis B	0.0038	0.0243	CbGeAlD
Medroxyprogesterone Acetate—Acne—Lamivudine—hepatitis B	0.00379	0.00618	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Telbivudine—hepatitis B	0.0037	0.00603	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Telbivudine—hepatitis B	0.00367	0.00599	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00366	0.00598	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Entecavir—hepatitis B	0.00364	0.00594	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00362	0.00591	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Telbivudine—hepatitis B	0.00362	0.00591	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Telbivudine—hepatitis B	0.00357	0.00583	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00356	0.0058	CcSEcCtD
Medroxyprogesterone Acetate—Influenza—Telbivudine—hepatitis B	0.00355	0.00579	CcSEcCtD
Medroxyprogesterone Acetate—Rectal haemorrhage—Lamivudine—hepatitis B	0.00353	0.00576	CcSEcCtD
Medroxyprogesterone Acetate—Bone disorder—Lamivudine—hepatitis B	0.00353	0.00576	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00353	0.00575	CcSEcCtD
Medroxyprogesterone Acetate—AR—blood—hepatitis B	0.00349	0.0223	CbGeAlD
Medroxyprogesterone Acetate—Hepatitis—Entecavir—hepatitis B	0.00346	0.00564	CcSEcCtD
Medroxyprogesterone Acetate—Drug interaction—Lamivudine—hepatitis B	0.00344	0.00561	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—blood—hepatitis B	0.00343	0.0219	CbGeAlD
Medroxyprogesterone Acetate—Oedema peripheral—Entecavir—hepatitis B	0.00341	0.00556	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal discomfort—Telbivudine—hepatitis B	0.0034	0.00555	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00338	0.00551	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00335	0.00546	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00333	0.00544	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00332	0.00541	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00331	0.0054	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0033	0.00538	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal pain—Lamivudine—hepatitis B	0.00323	0.00526	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Entecavir—hepatitis B	0.00312	0.0051	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Telbivudine—hepatitis B	0.0031	0.00506	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Entecavir—hepatitis B	0.00306	0.00499	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Entecavir—hepatitis B	0.00303	0.00494	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Entecavir—hepatitis B	0.00301	0.00491	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Telbivudine—hepatitis B	0.00299	0.00488	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00294	0.00479	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Adefovir Dipivoxil—hepatitis B	0.0029	0.00472	CcSEcCtD
Medroxyprogesterone Acetate—Mouth ulceration—Lamivudine—hepatitis B	0.00288	0.0047	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Adefovir Dipivoxil—hepatitis B	0.00284	0.00464	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Telbivudine—hepatitis B	0.00284	0.00464	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—blood—hepatitis B	0.00282	0.018	CbGeAlD
Medroxyprogesterone Acetate—Pharyngitis—Telbivudine—hepatitis B	0.00282	0.0046	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Telbivudine—hepatitis B	0.00279	0.00455	CcSEcCtD
Medroxyprogesterone Acetate—Sepsis—Lamivudine—hepatitis B	0.00277	0.00451	CcSEcCtD
Medroxyprogesterone Acetate—AR—liver—hepatitis B	0.00273	0.0174	CbGeAlD
Medroxyprogesterone Acetate—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00272	0.00443	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—liver—hepatitis B	0.00268	0.0171	CbGeAlD
Medroxyprogesterone Acetate—Mediastinal disorder—Telbivudine—hepatitis B	0.00256	0.00418	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00255	0.00415	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—blood—hepatitis B	0.00253	0.0161	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—blood—hepatitis B	0.00251	0.016	CbGeAlD
Medroxyprogesterone Acetate—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0025	0.00408	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Adefovir Dipivoxil—hepatitis B	0.0025	0.00408	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00248	0.00405	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Telbivudine—hepatitis B	0.00247	0.00403	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Entecavir—hepatitis B	0.00246	0.00401	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Entecavir—hepatitis B	0.00244	0.00398	CcSEcCtD
Medroxyprogesterone Acetate—Thirst—Lamivudine—hepatitis B	0.00243	0.00397	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Telbivudine—hepatitis B	0.00242	0.00395	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Entecavir—hepatitis B	0.00241	0.00393	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Telbivudine—hepatitis B	0.00239	0.0039	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Entecavir—hepatitis B	0.00239	0.00389	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Telbivudine—hepatitis B	0.00238	0.00388	CcSEcCtD
Medroxyprogesterone Acetate—Hypoglycaemia—Lamivudine—hepatitis B	0.00237	0.00387	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00235	0.00384	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00235	0.00383	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00233	0.0038	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Telbivudine—hepatitis B	0.0023	0.00374	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00229	0.00373	CcSEcCtD
Medroxyprogesterone Acetate—Migraine—Lamivudine—hepatitis B	0.00228	0.00372	CcSEcCtD
Medroxyprogesterone Acetate—Affect lability—Lamivudine—hepatitis B	0.00228	0.00372	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Telbivudine—hepatitis B	0.00223	0.00364	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Entecavir—hepatitis B	0.00222	0.00363	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—liver—hepatitis B	0.00221	0.0141	CbGeAlD
Medroxyprogesterone Acetate—Mood swings—Lamivudine—hepatitis B	0.00219	0.00358	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Entecavir—hepatitis B	0.00218	0.00356	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00218	0.00356	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Entecavir—hepatitis B	0.00216	0.00353	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Entecavir—hepatitis B	0.00212	0.00346	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Entecavir—hepatitis B	0.00212	0.00346	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00211	0.00344	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Telbivudine—hepatitis B	0.00211	0.00344	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Telbivudine—hepatitis B	0.00211	0.00344	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Telbivudine—hepatitis B	0.00211	0.00344	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00209	0.00341	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Lamivudine—hepatitis B	0.00208	0.0034	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00208	0.0034	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Telbivudine—hepatitis B	0.00208	0.00339	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00207	0.00338	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Lamivudine—hepatitis B	0.00207	0.00338	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Lamivudine—hepatitis B	0.00204	0.00333	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00204	0.00333	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Lamivudine—hepatitis B	0.00201	0.00329	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Entecavir—hepatitis B	0.00201	0.00328	CcSEcCtD
Medroxyprogesterone Acetate—Influenza—Lamivudine—hepatitis B	0.002	0.00326	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Lamivudine—hepatitis B	0.002	0.00326	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Telbivudine—hepatitis B	0.00198	0.00323	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—liver—hepatitis B	0.00198	0.0126	CbGeAlD
Medroxyprogesterone Acetate—Thrombocytopenia—Telbivudine—hepatitis B	0.00198	0.00322	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Telbivudine—hepatitis B	0.00196	0.0032	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00196	0.0032	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—liver—hepatitis B	0.00196	0.0125	CbGeAlD
Medroxyprogesterone Acetate—Sweating increased—Lamivudine—hepatitis B	0.00195	0.00318	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Entecavir—hepatitis B	0.00194	0.00317	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Entecavir—hepatitis B	0.00194	0.00317	CcSEcCtD
Medroxyprogesterone Acetate—Bronchitis—Lamivudine—hepatitis B	0.00192	0.00314	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal discomfort—Lamivudine—hepatitis B	0.00192	0.00313	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—blood—hepatitis B	0.00191	0.0122	CbGeAlD
Medroxyprogesterone Acetate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.0019	0.00309	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.0019	0.00309	CcSEcCtD
Medroxyprogesterone Acetate—Dysuria—Lamivudine—hepatitis B	0.00187	0.00305	CcSEcCtD
Medroxyprogesterone Acetate—Pollakiuria—Lamivudine—hepatitis B	0.00185	0.00301	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00184	0.003	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Telbivudine—hepatitis B	0.00183	0.00298	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Telbivudine—hepatitis B	0.00181	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Lamivudine—hepatitis B	0.0018	0.00294	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Lamivudine—hepatitis B	0.00178	0.0029	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Telbivudine—hepatitis B	0.00178	0.0029	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Entecavir—hepatitis B	0.00176	0.00288	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Lamivudine—hepatitis B	0.00175	0.00285	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00174	0.00284	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Telbivudine—hepatitis B	0.00174	0.00284	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Lamivudine—hepatitis B	0.00174	0.00284	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Lamivudine—hepatitis B	0.00174	0.00284	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00172	0.00281	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Lamivudine—hepatitis B	0.00171	0.00279	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0017	0.00277	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Lamivudine—hepatitis B	0.00169	0.00275	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Lamivudine—hepatitis B	0.00168	0.00274	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Entecavir—hepatitis B	0.00168	0.00274	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Lamivudine—hepatitis B	0.00167	0.00273	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Telbivudine—hepatitis B	0.00166	0.00271	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Telbivudine—hepatitis B	0.00165	0.00269	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00164	0.00268	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Entecavir—hepatitis B	0.00163	0.00265	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Lamivudine—hepatitis B	0.0016	0.00261	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Telbivudine—hepatitis B	0.0016	0.0026	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Telbivudine—hepatitis B	0.0016	0.0026	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Lamivudine—hepatitis B	0.00159	0.00259	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Lamivudine—hepatitis B	0.00157	0.00257	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Entecavir—hepatitis B	0.00156	0.00255	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Entecavir—hepatitis B	0.00155	0.00253	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Entecavir—hepatitis B	0.00155	0.00253	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Entecavir—hepatitis B	0.00154	0.00251	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00152	0.00249	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Lamivudine—hepatitis B	0.00151	0.00247	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Adefovir Dipivoxil—hepatitis B	0.00151	0.00247	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00151	0.00246	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Adefovir Dipivoxil—hepatitis B	0.0015	0.00245	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—liver—hepatitis B	0.0015	0.00953	CbGeAlD
Medroxyprogesterone Acetate—Nausea—Entecavir—hepatitis B	0.00146	0.00238	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Telbivudine—hepatitis B	0.00145	0.00236	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Lamivudine—hepatitis B	0.00145	0.00236	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Lamivudine—hepatitis B	0.00144	0.00235	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Lamivudine—hepatitis B	0.00144	0.00234	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Telbivudine—hepatitis B	0.00143	0.00233	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Adefovir Dipivoxil—hepatitis B	0.00142	0.00232	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Lamivudine—hepatitis B	0.00142	0.00231	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Lamivudine—hepatitis B	0.00139	0.00227	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Lamivudine—hepatitis B	0.00139	0.00227	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Telbivudine—hepatitis B	0.00138	0.00225	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Lamivudine—hepatitis B	0.00137	0.00224	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Lamivudine—hepatitis B	0.00137	0.00223	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Lamivudine—hepatitis B	0.00137	0.00223	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Lamivudine—hepatitis B	0.00135	0.00221	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Lamivudine—hepatitis B	0.00135	0.0022	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Lamivudine—hepatitis B	0.00134	0.00219	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Telbivudine—hepatitis B	0.00134	0.00218	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Lamivudine—hepatitis B	0.00131	0.00213	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Lamivudine—hepatitis B	0.00129	0.00211	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Lamivudine—hepatitis B	0.00129	0.0021	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Telbivudine—hepatitis B	0.00128	0.00209	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Lamivudine—hepatitis B	0.00127	0.00208	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Telbivudine—hepatitis B	0.00127	0.00208	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Telbivudine—hepatitis B	0.00127	0.00207	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Telbivudine—hepatitis B	0.00126	0.00206	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Lamivudine—hepatitis B	0.00126	0.00205	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Lamivudine—hepatitis B	0.00125	0.00204	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Lamivudine—hepatitis B	0.00125	0.00204	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Lamivudine—hepatitis B	0.00123	0.002	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Lamivudine—hepatitis B	0.00121	0.00197	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Telbivudine—hepatitis B	0.0012	0.00196	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Lamivudine—hepatitis B	0.00119	0.00194	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Lamivudine—hepatitis B	0.00119	0.00194	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Lamivudine—hepatitis B	0.00119	0.00194	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Lamivudine—hepatitis B	0.00118	0.00193	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00118	0.00192	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Lamivudine—hepatitis B	0.00117	0.00191	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Lamivudine—hepatitis B	0.00116	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Lamivudine—hepatitis B	0.00115	0.00187	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Lamivudine—hepatitis B	0.00114	0.00186	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Lamivudine—hepatitis B	0.00114	0.00186	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Lamivudine—hepatitis B	0.00113	0.00184	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Lamivudine—hepatitis B	0.00112	0.00183	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Lamivudine—hepatitis B	0.00112	0.00182	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Lamivudine—hepatitis B	0.00111	0.00182	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Lamivudine—hepatitis B	0.00111	0.0018	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Lamivudine—hepatitis B	0.0011	0.00179	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Lamivudine—hepatitis B	0.00108	0.00177	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Lamivudine—hepatitis B	0.00106	0.00173	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00104	0.00169	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Lamivudine—hepatitis B	0.00103	0.00168	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Lamivudine—hepatitis B	0.00102	0.00167	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Lamivudine—hepatitis B	0.00101	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Lamivudine—hepatitis B	0.00101	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Lamivudine—hepatitis B	0.001	0.00163	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Lamivudine—hepatitis B	0.000989	0.00161	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000982	0.0016	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Lamivudine—hepatitis B	0.000981	0.0016	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Lamivudine—hepatitis B	0.000973	0.00159	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Lamivudine—hepatitis B	0.000938	0.00153	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Lamivudine—hepatitis B	0.00093	0.00152	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Lamivudine—hepatitis B	0.000904	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Lamivudine—hepatitis B	0.000899	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Lamivudine—hepatitis B	0.000899	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000882	0.00383	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL10—hepatitis B	0.000877	0.00381	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKR1B1—hepatitis B	0.000866	0.00377	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.000857	0.00373	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000854	0.00371	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000842	0.00366	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—hepatitis B	0.000842	0.00366	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Lamivudine—hepatitis B	0.000838	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GGT2—hepatitis B	0.000831	0.00361	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hepatitis B	0.000819	0.00356	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Lamivudine—hepatitis B	0.000816	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—CDKN2A—hepatitis B	0.000808	0.00351	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Lamivudine—hepatitis B	0.000805	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000804	0.00349	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000792	0.00344	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—HLA-A—hepatitis B	0.000784	0.00341	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—NOS2—hepatitis B	0.000782	0.0034	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.00078	0.00339	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Lamivudine—hepatitis B	0.000778	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—hepatitis B	0.000778	0.00338	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—HLA-A—hepatitis B	0.000773	0.00336	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000772	0.00336	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000769	0.00334	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000762	0.00331	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Lamivudine—hepatitis B	0.000752	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Lamivudine—hepatitis B	0.000723	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Lamivudine—hepatitis B	0.000717	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Lamivudine—hepatitis B	0.000717	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Lamivudine—hepatitis B	0.000713	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000698	0.00303	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000694	0.00302	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—hepatitis B	0.00068	0.00295	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Lamivudine—hepatitis B	0.000676	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000675	0.00293	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000658	0.00286	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—hepatitis B	0.000651	0.00283	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000626	0.00272	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hepatitis B	0.000626	0.00272	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000614	0.00267	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000612	0.00266	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000609	0.00265	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000609	0.00265	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IFNG—hepatitis B	0.0006	0.00261	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SAG—hepatitis B	0.000565	0.00246	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—APOBEC3G—hepatitis B	0.000565	0.00246	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000565	0.00245	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000557	0.00242	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000549	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CDKN2A—hepatitis B	0.000537	0.00233	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—IFNG—hepatitis B	0.000536	0.00233	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CDKN2A—hepatitis B	0.000529	0.0023	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—hepatitis B	0.000524	0.00228	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IFNG—hepatitis B	0.000523	0.00228	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.00052	0.00226	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IFNG—hepatitis B	0.000515	0.00224	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000509	0.00221	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000507	0.0022	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CYP2A6—hepatitis B	0.000503	0.00219	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000503	0.00218	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000481	0.00209	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—CTNNB1—hepatitis B	0.000481	0.00209	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—FAS—hepatitis B	0.000479	0.00208	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—IL2—hepatitis B	0.000476	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000474	0.00206	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NR0B2—hepatitis B	0.000472	0.00205	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—CDKN1A—hepatitis B	0.00047	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000469	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—PTEN—hepatitis B	0.000469	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL2—hepatitis B	0.000465	0.00202	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NR0B2—hepatitis B	0.000465	0.00202	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000464	0.00202	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000462	0.00201	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL2—hepatitis B	0.000458	0.00199	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GOT2—hepatitis B	0.000455	0.00198	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hepatitis B	0.000454	0.00197	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—CTNNB1—hepatitis B	0.000453	0.00197	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CTNNB1—hepatitis B	0.000449	0.00195	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—NFKB1—hepatitis B	0.000446	0.00194	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CTNNB1—hepatitis B	0.000442	0.00192	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—hepatitis B	0.000441	0.00192	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—PTEN—hepatitis B	0.000438	0.0019	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000436	0.00189	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—PTEN—hepatitis B	0.000431	0.00187	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKR1B1—hepatitis B	0.000428	0.00186	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000424	0.00184	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000413	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—NFKB1—hepatitis B	0.000412	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GGT2—hepatitis B	0.00041	0.00178	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000409	0.00178	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—hepatitis B	0.000404	0.00175	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—CDKN1A—hepatitis B	0.000402	0.00175	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—PTEN—hepatitis B	0.000401	0.00174	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RIT2—hepatitis B	0.000396	0.00172	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SAG—hepatitis B	0.000396	0.00172	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GOT1—hepatitis B	0.000393	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GGT1—hepatitis B	0.000393	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.00039	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NR0B2—hepatitis B	0.000387	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000384	0.00167	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hepatitis B	0.000381	0.00165	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—hepatitis B	0.000378	0.00164	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000372	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—TGFB1—hepatitis B	0.000371	0.00161	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000371	0.00161	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—TGFB1—hepatitis B	0.000366	0.00159	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TGFB1—hepatitis B	0.000363	0.00158	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000362	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000358	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000357	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TGFB1—hepatitis B	0.000357	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000333	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—HNF4A—hepatitis B	0.000327	0.00142	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—HNF4A—hepatitis B	0.000322	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000319	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000315	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IL6—hepatitis B	0.000313	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SAG—hepatitis B	0.000312	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RIT2—hepatitis B	0.000312	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000307	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000307	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000306	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—hepatitis B	0.000299	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000298	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NR0B2—hepatitis B	0.000295	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—hepatitis B	0.000294	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL6—hepatitis B	0.000273	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00027	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—CTNNB1—hepatitis B	0.000269	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL6—hepatitis B	0.000269	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—GOT2—hepatitis B	0.000268	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—HNF4A—hepatitis B	0.000268	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—CDKN1A—hepatitis B	0.000263	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000261	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.00026	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—hepatitis B	0.000259	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000255	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000255	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000253	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—IL6—hepatitis B	0.000251	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP2A6—hepatitis B	0.000249	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000243	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—hepatitis B	0.000237	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000237	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—CDKN1A—hepatitis B	0.000236	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000235	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PTEN—hepatitis B	0.000235	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000233	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000232	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—GOT1—hepatitis B	0.000232	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000232	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NR0B2—hepatitis B	0.000227	0.000987	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000226	0.000982	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GOT2—hepatitis B	0.000225	0.000977	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NR0B2—hepatitis B	0.000224	0.000972	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00022	0.000956	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000219	0.000953	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TGFB1—hepatitis B	0.000218	0.000946	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000211	0.000917	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.00021	0.000911	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ALB—hepatitis B	0.000209	0.000908	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—HNF4A—hepatitis B	0.000204	0.000888	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—hepatitis B	0.000203	0.000884	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000201	0.000874	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000197	0.000856	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000196	0.000854	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000196	0.000852	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000195	0.000848	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GGT1—hepatitis B	0.000194	0.000843	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GOT1—hepatitis B	0.000194	0.000843	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000187	0.000812	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RIT2—hepatitis B	0.000183	0.000796	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SAG—hepatitis B	0.000183	0.000796	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000177	0.000769	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000176	0.000764	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000174	0.000755	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CCR5—hepatitis B	0.000173	0.000752	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000171	0.000744	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HLA-A—hepatitis B	0.000169	0.000733	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—hepatitis B	0.000164	0.000713	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000163	0.000706	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000161	0.000702	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTEN—hepatitis B	0.000159	0.000693	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HNF4A—hepatitis B	0.000157	0.000684	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL10—hepatitis B	0.000156	0.000679	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HNF4A—hepatitis B	0.000155	0.000674	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000152	0.00066	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—hepatitis B	0.000147	0.000639	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NOS2—hepatitis B	0.000147	0.000637	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000142	0.000616	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000134	0.000582	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL10—hepatitis B	0.000123	0.000535	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000123	0.000532	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCR5—hepatitis B	0.000121	0.000526	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKR1B1—hepatitis B	0.00012	0.000523	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GGT2—hepatitis B	0.000115	0.000501	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD4—hepatitis B	0.000109	0.000472	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—F2—hepatitis B	0.000104	0.000452	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALB—hepatitis B	0.000103	0.000449	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.97e-05	0.000433	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKR1B1—hepatitis B	9.79e-05	0.000426	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CTNNB1—hepatitis B	9.65e-05	0.000419	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR5—hepatitis B	9.55e-05	0.000415	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDKN1A—hepatitis B	9.42e-05	0.00041	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTEN—hepatitis B	9.4e-05	0.000409	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GGT2—hepatitis B	9.39e-05	0.000408	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—F2—hepatitis B	8.2e-05	0.000356	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTEN—hepatitis B	7.88e-05	0.000342	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—hepatitis B	7.8e-05	0.000339	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL10—hepatitis B	7.23e-05	0.000314	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2—hepatitis B	7e-05	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2A6—hepatitis B	6.99e-05	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CTNNB1—hepatitis B	6.76e-05	0.000294	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1A—hepatitis B	6.6e-05	0.000287	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTEN—hepatitis B	6.59e-05	0.000286	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NFKB1—hepatitis B	6.55e-05	0.000285	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.52e-05	0.000283	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKR1B1—hepatitis B	6.46e-05	0.000281	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GOT2—hepatitis B	6.32e-05	0.000275	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GGT2—hepatitis B	6.19e-05	0.000269	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—hepatitis B	5.87e-05	0.000255	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2A6—hepatitis B	5.69e-05	0.000247	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR5—hepatitis B	5.61e-05	0.000244	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2—hepatitis B	5.52e-05	0.00024	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—hepatitis B	5.46e-05	0.000237	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GGT1—hepatitis B	5.46e-05	0.000237	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GOT1—hepatitis B	5.46e-05	0.000237	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CTNNB1—hepatitis B	5.33e-05	0.000232	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.3e-05	0.000231	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1A—hepatitis B	5.21e-05	0.000226	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTEN—hepatitis B	5.19e-05	0.000226	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NFKB1—hepatitis B	5.17e-05	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GOT2—hepatitis B	5.14e-05	0.000224	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.97e-05	0.000216	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—F2—hepatitis B	4.81e-05	0.000209	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—hepatitis B	4.49e-05	0.000195	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GGT1—hepatitis B	4.44e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GOT1—hepatitis B	4.44e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—hepatitis B	4.31e-05	0.000187	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—hepatitis B	4.11e-05	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.05e-05	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.75e-05	0.000163	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—hepatitis B	3.55e-05	0.000154	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GOT2—hepatitis B	3.39e-05	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—hepatitis B	3.24e-05	0.000141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2—hepatitis B	3.24e-05	0.000141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CTNNB1—hepatitis B	3.13e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1A—hepatitis B	3.06e-05	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTEN—hepatitis B	3.05e-05	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NFKB1—hepatitis B	3.03e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GOT1—hepatitis B	2.93e-05	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GGT1—hepatitis B	2.93e-05	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—hepatitis B	2.9e-05	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—hepatitis B	2.53e-05	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—hepatitis B	2.36e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTEN—hepatitis B	2.21e-05	9.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—hepatitis B	2.08e-05	9.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—hepatitis B	1.9e-05	8.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTEN—hepatitis B	1.8e-05	7.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—hepatitis B	1.56e-05	6.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTEN—hepatitis B	1.19e-05	5.17e-05	CbGpPWpGaD
